1. Home
  2. WKSP vs OSRH Comparison

WKSP vs OSRH Comparison

Compare WKSP & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Worksport Ltd.

WKSP

Worksport Ltd.

HOLD

Current Price

$1.97

Market Cap

20.4M

ML Signal

HOLD

Logo OSR Holdings Inc.

OSRH

OSR Holdings Inc.

HOLD

Current Price

$0.63

Market Cap

18.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
WKSP
OSRH
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
20.4M
18.4M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WKSP
OSRH
Price
$1.97
$0.63
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$9.25
N/A
AVG Volume (30 Days)
158.8K
2.9M
Earning Date
11-13-2025
02-24-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$14,286,679.00
N/A
Revenue This Year
$142.95
N/A
Revenue Next Year
$109.62
N/A
P/E Ratio
N/A
N/A
Revenue Growth
123.37
N/A
52 Week Low
$1.85
$0.45
52 Week High
$11.00
$11.84

Technical Indicators

Market Signals
Indicator
WKSP
OSRH
Relative Strength Index (RSI) 36.37 46.39
Support Level $1.85 $0.69
Resistance Level $2.10 $0.84
Average True Range (ATR) 0.15 0.09
MACD -0.02 -0.00
Stochastic Oscillator 19.60 21.00

Price Performance

Historical Comparison
WKSP
OSRH

About WKSP Worksport Ltd.

Worksport Ltd through its subsidiaries, designs, develops, manufactures, and owns the IP on a variety of tonneau covers, solar integrations, and NP (Non-Parasitic), Hydrogen-based true green energy solutions for the sustainable, clean energy, and automotive industries. The company's product includes soft vinyl tonneau covers and hard aluminum tonneau covers. It operates in two reporting segments for financial reporting purposes: Hard Tonneau Covers and Soft Tonneau Covers. Geographically, the company operates in Canada, United States and Other Countries.

About OSRH OSR Holdings Inc.

OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.

Share on Social Networks: